Imagine someone had been managing your data, and then you looked. | e-Patients.net

Imagine someone had been managing your data, and then you looked. | e-Patients.net

4:15 min video (IP) Improvements in the treatment of advanced ovarian cancer

Addressing the challenge: current and future directions in ovarian cancer therapy.

The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper ab

The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum.

The origin of serous ovarian cancer may be found in the uterus: A novel hypothesis

Preoperative serum CA-125 levels and risk of suboptimal cytoreduction in ovarian cancer: A meta-analysis

Maturitas : Hormone replacement after gynaecological cancer

Maturitas : Hormone replacement therapy (HRT), breast cancer and tumor pathology

Risks of Lynch Syndrome Cancers for MSH6 Mutation Carriers - multinational study

Changes in the Mouse Estrus Cycle in Response to Brca1 Inactivation Suggest a Potential Link between Risk Factors for Familial and Sporadic Ovarian Cancer

in research (mice)